Paramyxovirus by Alice Chow
... The virus will enter into the host cell through receptor mediated endocytosis. Hemagglutinin-neuraminidase will bind to the sialic acid containing receptor on the host cell. The process is aided by the fusion protein. Once bound, the virus will release its RNA, NP, and enzymes into the cytoplasm of ...
... The virus will enter into the host cell through receptor mediated endocytosis. Hemagglutinin-neuraminidase will bind to the sialic acid containing receptor on the host cell. The process is aided by the fusion protein. Once bound, the virus will release its RNA, NP, and enzymes into the cytoplasm of ...
Klinikum der Universität München • Der Vorstand • Lindwurmstr
... the liver, severe disease of the immune system (f. i. symptomatic HIV infection, or HIV with less than 200 CD4/mm³); therapy weakening the immune system, such as corticosteroids (oral or injection), or other immunosuppressive therapies, chemotherapy or radiotherapy; pregnancy, desensibilisation -the ...
... the liver, severe disease of the immune system (f. i. symptomatic HIV infection, or HIV with less than 200 CD4/mm³); therapy weakening the immune system, such as corticosteroids (oral or injection), or other immunosuppressive therapies, chemotherapy or radiotherapy; pregnancy, desensibilisation -the ...
vaccination
... 2-Toxoid : amodified bacterial toxin made nontxic but retains its capacity to stimulate formation of antitoxin. 3-Immune gloubin (Ig) :antibodies containing solution derived from human blood by fractionation of large pools of plasma used to maintain immunity in immunization. 4-Antitoxin: antibodies ...
... 2-Toxoid : amodified bacterial toxin made nontxic but retains its capacity to stimulate formation of antitoxin. 3-Immune gloubin (Ig) :antibodies containing solution derived from human blood by fractionation of large pools of plasma used to maintain immunity in immunization. 4-Antitoxin: antibodies ...
this presentation (Pt. 2) - cacuss/aseucc 2007
... doses in childhood; ≥ 3 doses in adolescence/adulthood). – Serology for poliovirus serotypes 1, 2, 3 is available, but not routinely recommended as proof of immunity. • Boosters of IPV no longer recommended for adults residing in N. America, as the western hemisphere was declared free of wild poliov ...
... doses in childhood; ≥ 3 doses in adolescence/adulthood). – Serology for poliovirus serotypes 1, 2, 3 is available, but not routinely recommended as proof of immunity. • Boosters of IPV no longer recommended for adults residing in N. America, as the western hemisphere was declared free of wild poliov ...
COULD PARENTS BE HELD LIABLE FOR NOT IMMUNIZING THEIR CHILDREN?
... Although most vaccines are highly effective, vaccination does not confer 100% immunity to all those immunized, and some individuals are unable to receive vaccinations. But the phenomenon of herd immunity, which arises when a large enough percentage of the population is vaccinated, more completely pr ...
... Although most vaccines are highly effective, vaccination does not confer 100% immunity to all those immunized, and some individuals are unable to receive vaccinations. But the phenomenon of herd immunity, which arises when a large enough percentage of the population is vaccinated, more completely pr ...
Epidemiological Unit Introduction Mumps is an acute viral disease
... Mumps vaccines are available, either as monovalent or in combination with measles and rubella vaccine (MMR vaccine). The vaccines are highly protective and without significant adverse effects. Mumps vaccine is still not available through national EPI programme in Sri Lanka. At present mumps vaccine ...
... Mumps vaccines are available, either as monovalent or in combination with measles and rubella vaccine (MMR vaccine). The vaccines are highly protective and without significant adverse effects. Mumps vaccine is still not available through national EPI programme in Sri Lanka. At present mumps vaccine ...
recurrent outbreaks of measles, chickenpox and
... models (1-9). Although useful in describ- recognized (3, 10) but whether or not there ing single outbreaks of a few months' dura- is seasonal variation in the contact rate has tion in small populations, deterministic not been investigated, models have not predicted undamped recurThe contact rate of ...
... models (1-9). Although useful in describ- recognized (3, 10) but whether or not there ing single outbreaks of a few months' dura- is seasonal variation in the contact rate has tion in small populations, deterministic not been investigated, models have not predicted undamped recurThe contact rate of ...
ORGANIC OUTREACH
... programs is far more cost-effective than case management and outbreak control • Mandatory immunization programs, which include both newly hired and currently employed persons, are more effective than voluntary programs in ensuring that susceptible persons are vaccinated ...
... programs is far more cost-effective than case management and outbreak control • Mandatory immunization programs, which include both newly hired and currently employed persons, are more effective than voluntary programs in ensuring that susceptible persons are vaccinated ...
Slow Virus Diseases of the Central Nervous System
... subacute degenerations of the brain that strongly suggested to us the possibility of a slow virus infection. One of these suddenly provided clues showing that it was, in fact, caused by such an infection: namely, Dawson's or subacute type A inclusion body encephalitis, called, in Europe, Van Bogaert ...
... subacute degenerations of the brain that strongly suggested to us the possibility of a slow virus infection. One of these suddenly provided clues showing that it was, in fact, caused by such an infection: namely, Dawson's or subacute type A inclusion body encephalitis, called, in Europe, Van Bogaert ...
Too sick for school?
... symptoms. Contact have a chronic your doctor before infection (not the returning to school. first outbreak) and no symptoms. ... until antibiotic treatment starts. Sores should be covered with watertight ...
... symptoms. Contact have a chronic your doctor before infection (not the returning to school. first outbreak) and no symptoms. ... until antibiotic treatment starts. Sores should be covered with watertight ...
Mathematical modelling of infectious disease transmission
... • Vaccinated people are less likely to become infected and less likely to infect others. Therefore, vaccines can protect vaccinated and unvaccinated people. • If some people are vaccinated, epidemics may be smaller. • If enough people are vaccinated, epidemics should not spread and there is “herd im ...
... • Vaccinated people are less likely to become infected and less likely to infect others. Therefore, vaccines can protect vaccinated and unvaccinated people. • If some people are vaccinated, epidemics may be smaller. • If enough people are vaccinated, epidemics should not spread and there is “herd im ...
Herd-immunity-for-IMCV - International Medical Council on
... include cowpox(vaccinia), smallpox(variola), and monkeypox. Mutations do occur in these viruses, but at a very slow rate. Between October 1970 and May 1971 a poxvirus was isolated from some symptomatic patients in West Africa. That virus is now known as “human monkeypox.” Monkeypox got its name beca ...
... include cowpox(vaccinia), smallpox(variola), and monkeypox. Mutations do occur in these viruses, but at a very slow rate. Between October 1970 and May 1971 a poxvirus was isolated from some symptomatic patients in West Africa. That virus is now known as “human monkeypox.” Monkeypox got its name beca ...
FIU Immunization Documentation Form
... the United States. Meningitis cases should be reported to state or local health departments to assure follow-up of close contacts and recognize outbreaks. The Advisory Committee on Immunization Practices (ACIP) recommends that all people at risk should receive one dose of the conjugate vaccine (Mena ...
... the United States. Meningitis cases should be reported to state or local health departments to assure follow-up of close contacts and recognize outbreaks. The Advisory Committee on Immunization Practices (ACIP) recommends that all people at risk should receive one dose of the conjugate vaccine (Mena ...
elimination and eradication of diseases, with special reference to
... Infectious diseases occur as the end result of the interaction of three major factorsthe agent, the mode of transmission and the host. The relationship between these three factors is known as the chain of infection. The environment is an integral part of this relationship in that it affects individu ...
... Infectious diseases occur as the end result of the interaction of three major factorsthe agent, the mode of transmission and the host. The relationship between these three factors is known as the chain of infection. The environment is an integral part of this relationship in that it affects individu ...
Fever and a Rash Professor Alison M Kesson Infectious Diseases and Microbiology
... extravasation of blood from capillaries, often appear over a short time in crops or showers. Isolated petechiae are a common finding in early blood stream infection. Lesions that blanch under pressure are not extravascular blood. Ecchymosis – all bruises are areas of bleeding into the skin that diff ...
... extravasation of blood from capillaries, often appear over a short time in crops or showers. Isolated petechiae are a common finding in early blood stream infection. Lesions that blanch under pressure are not extravascular blood. Ecchymosis – all bruises are areas of bleeding into the skin that diff ...
Rubella Clinical Signs and Symptoms
... disease resulting from infection with rubella virus. Rubella is transmitted via respiratory droplets, or direct contact with nasal/throat secretions, from infected individuals. The incubation period is 12-23 days, usually14 days until appearance of rash. Individuals may be infectious 7 days before t ...
... disease resulting from infection with rubella virus. Rubella is transmitted via respiratory droplets, or direct contact with nasal/throat secretions, from infected individuals. The incubation period is 12-23 days, usually14 days until appearance of rash. Individuals may be infectious 7 days before t ...
Characterization of Major Structural Proteins of Measles
... determined in the absence and presence of various concentrations of unlabelled antibodies. Delineation of non-overlapping antigenic sites by this method was, in general, unambiguous. Only homologous antibodies effectively competed with binding of A 144(P) and C6(P). Other antibodies, including A56(N ...
... determined in the absence and presence of various concentrations of unlabelled antibodies. Delineation of non-overlapping antigenic sites by this method was, in general, unambiguous. Only homologous antibodies effectively competed with binding of A 144(P) and C6(P). Other antibodies, including A56(N ...
Rhytidectomy: Evolution and Current Concepts
... • Linear, negative-sense, single stranded RNA virus • Highest incidence in children sparing those under 6 months • Decline in recent decade from immunization programs ...
... • Linear, negative-sense, single stranded RNA virus • Highest incidence in children sparing those under 6 months • Decline in recent decade from immunization programs ...
VIRUS
... fusion of cells in human cell culture. It is the single most serious cause of bronchiolitis and pneumonitis in infants. Properties of the Virus: RS virus does not hemagglutinate. ...
... fusion of cells in human cell culture. It is the single most serious cause of bronchiolitis and pneumonitis in infants. Properties of the Virus: RS virus does not hemagglutinate. ...
FACT SHEET - Kymbrook Pre School
... Serious complications of measles infection can occur and secondary infections such as ear infections (approx 1 in 20), bronchitis/pneumonia (approx 1 in 25), convulsions (approx 1 in 200) and in rare cases, encephalitis (infection of the brain) or meningitis (approx 1 in 1000) may occur. The likelih ...
... Serious complications of measles infection can occur and secondary infections such as ear infections (approx 1 in 20), bronchitis/pneumonia (approx 1 in 25), convulsions (approx 1 in 200) and in rare cases, encephalitis (infection of the brain) or meningitis (approx 1 in 1000) may occur. The likelih ...
Measles Virus Infection: Mechanisms of Immune Suppression
... General symptoms of an acute MV infection consist of a maculopapular rash, dry cough, coryza, fever, conjunctivitis and photophobia, usually preceded by characteristic spots on the mucosal surface of the mouth, called Koplik spots. Complications consist of diarrroea, pneumonia, laryngotracheobronchi ...
... General symptoms of an acute MV infection consist of a maculopapular rash, dry cough, coryza, fever, conjunctivitis and photophobia, usually preceded by characteristic spots on the mucosal surface of the mouth, called Koplik spots. Complications consist of diarrroea, pneumonia, laryngotracheobronchi ...
Rubella (German Measles)
... pregnant women who has contracted the disease. Rubella infection in first trimester of pregnancy, may cause birth defect, prematurity, or even fetal death. ...
... pregnant women who has contracted the disease. Rubella infection in first trimester of pregnancy, may cause birth defect, prematurity, or even fetal death. ...
Measles
Measles, also known as morbilli, rubeola, or red measles, is a highly contagious infection caused by the measles virus. Initial signs and symptoms typically include fever, often greater than 40 °C (104.0 °F), cough, runny nose, and red eyes. Two or three days after the start of symptoms, small white spots may form inside the mouth, known as Koplik's spots. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Complications occur in about 30% and may include diarrhea, blindness, inflammation of the brain, and pneumonia among others. Rubella (German measles) and roseola are different diseases.Measles is an airborne disease which spreads easily through the coughs and sneezes of those infected. It may also be spread through contact with saliva or nasal secretions. Nine out of ten people who are not immune who share living space with an infected person will catch it. People are infectious to others from four days before to four days after the start of the rash. People usually only get the disease at most once. Testing for the virus in suspected cases is important for public health efforts.The measles vaccine is effective at preventing the disease. Vaccination has resulted in a 75% decrease in deaths from measles between 2000 and 2013 with about 85% of children globally being currently vaccinated. No specific treatment is available. Supportive care may improve outcomes. This may include giving oral rehydration solution (slightly sweet and salty fluids), healthy food, and medications to control the fever. Antibiotics may be used if a secondary bacterial infection such as pneumonia occurs. Vitamin A supplementation is also recommended in the developing world.Measles affects about 20 million people a year, primarily in the developing areas of Africa and Asia. It causes the most vaccine-preventable deaths of any disease. It resulted in about 96,000 deaths in 2013, down from 545,000 deaths in 1990. In 1980, the disease is estimated to have caused 2.6 million deaths per year. Before immunization in the United States between three and four million cases occurred each year. Most of those who are infected and who die are less than five years old. The risk of death among those infected is usually 0.2%, but may be up to 10% in those who have malnutrition. It is not believed to affect other animals.